The EU is setting up emergency funds for the development of COVID-19 vaccines

The European Commission decided to use a $2.6 billion Emergency Support Instrument (ESI) to advance the ability of vaccine production.

In addition, funds can be used to research and treat new corona infections.

More than 90 new coronavirus vaccines are currently being developed, and eight of them are currently in the clinical trials phase. However, experts say that the large-scale manufacture of a successful vaccine may be as challenging as developing one.